{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,16]],"date-time":"2026-03-16T11:05:28Z","timestamp":1773659128956,"version":"3.50.1"},"reference-count":45,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2008,11,1]],"date-time":"2008-11-01T00:00:00Z","timestamp":1225497600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["International Journal of Radiation Oncology*Biology*Physics"],"published-print":{"date-parts":[[2008,11]]},"DOI":"10.1016\/j.ijrobp.2008.06.1923","type":"journal-article","created":{"date-parts":[[2008,9,28]],"date-time":"2008-09-28T08:20:03Z","timestamp":1222590003000},"page":"927-934","source":"Crossref","is-referenced-by-count":19,"title":["Erythropoietin Augments Survival of Glioma Cells After Radiation and Temozolomide"],"prefix":"10.1016","volume":"72","author":[{"given":"Imam","family":"Hassouna","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Swetlana","family":"Sperling","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ella","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Walter","family":"Schulz-Schaeffer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Margret","family":"Rave-Fr\u00e4nk","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Martin","family":"Hasselblatt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wolfgang","family":"Jelkmann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alf","family":"Giese","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hannelore","family":"Ehrenreich","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijrobp.2008.06.1923_bib1","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1056\/NEJMoa043330","article-title":"Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma","volume":"352","author":"Stupp","year":"2005","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ijrobp.2008.06.1923_bib2","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1007\/s11864-006-0026-5","article-title":"Managing the cognitive effects of brain tumor radiation therapy","volume":"7","author":"Butler","year":"2006","journal-title":"Curr Treat Options Oncol"},{"key":"10.1016\/j.ijrobp.2008.06.1923_bib3","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1097\/01.wco.0000191511.52745.99","article-title":"Cognitive sequelae of brain tumor treatment","volume":"18","author":"Byrne","year":"2005","journal-title":"Curr Opin Neurol"},{"key":"10.1016\/j.ijrobp.2008.06.1923_bib4","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1111\/j.1600-0609.2007.00818.x","article-title":"Erythropoietin after a century of research: Younger than ever","volume":"78","author":"Jelkmann","year":"2007","journal-title":"Eur J Haematol"},{"key":"10.1016\/j.ijrobp.2008.06.1923_bib5","doi-asserted-by":"crossref","first-page":"4635","DOI":"10.1073\/pnas.95.8.4635","article-title":"In vivo evidence that erythropoietin protects neurons from ischemic damage","volume":"95","author":"Sakanaka","year":"1998","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.ijrobp.2008.06.1923_bib6","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1097\/00004647-199906000-00007","article-title":"A potential role for erythropoietin in focal permanent cerebral ischemia in mice","volume":"19","author":"Bernaudin","year":"1999","journal-title":"J Cereb Blood Flow Metab"},{"key":"10.1016\/j.ijrobp.2008.06.1923_bib7","doi-asserted-by":"crossref","first-page":"10526","DOI":"10.1073\/pnas.97.19.10526","article-title":"Erythropoietin crosses the blood-brain barrier to protect against experimental brain injury","volume":"97","author":"Brines","year":"2000","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.ijrobp.2008.06.1923_bib8","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1093\/brain\/awh703","article-title":"Global brain atrophy after unilateral parietal lesion and its prevention by erythropoietin","volume":"129","author":"Siren","year":"2006","journal-title":"Brain"},{"key":"10.1016\/j.ijrobp.2008.06.1923_bib9","doi-asserted-by":"crossref","first-page":"2577","DOI":"10.1093\/brain\/awm203","article-title":"Exploring recombinant human erythropoietin in chronic progressive multiple sclerosis","volume":"130","author":"Ehrenreich","year":"2007","journal-title":"Brain"},{"key":"10.1016\/j.ijrobp.2008.06.1923_bib10","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1007\/BF03402029","article-title":"Erythropoietin therapy for acute stroke is both safe and beneficial","volume":"8","author":"Ehrenreich","year":"2002","journal-title":"Mol Med"},{"key":"10.1016\/j.ijrobp.2008.06.1923_bib11","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1038\/sj.mp.4001907","article-title":"Improvement of cognitive functions in chronic schizophrenic patients by recombinant human erythropoietin","volume":"12","author":"Ehrenreich","year":"2007","journal-title":"Mol Psychiatry"},{"key":"10.1016\/j.ijrobp.2008.06.1923_bib12","doi-asserted-by":"crossref","first-page":"1804","DOI":"10.1096\/fj.00-0857fje","article-title":"Erythropoietin and erythropoietin receptors in the peripheral nervous system: Changes after nerve injury","volume":"15","author":"Campana","year":"2001","journal-title":"FASEB J"},{"key":"10.1016\/j.ijrobp.2008.06.1923_bib13","doi-asserted-by":"crossref","first-page":"2258","DOI":"10.1073\/pnas.042693799","article-title":"Erythropoietin prevents motor neuron apoptosis and neurologic disability in experimental spinal cord ischemic injury","volume":"99","author":"Celik","year":"2002","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.ijrobp.2008.06.1923_bib14","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.ydbio.2004.08.025","article-title":"The role of erythropoietin in regulating angiogenesis","volume":"276","author":"Kertesz","year":"2004","journal-title":"Dev Biol"},{"key":"10.1016\/j.ijrobp.2008.06.1923_bib15","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1002\/ana.20285","article-title":"A novel endogenous erythropoietin mediated pathway prevents axonal degeneration","volume":"56","author":"Keswani","year":"2004","journal-title":"Ann Neurol"},{"key":"10.1016\/j.ijrobp.2008.06.1923_bib16","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/0006-8993(93)90850-M","article-title":"Trophic effect of erythropoietin and other hematopoietic factors on central cholinergic neurons in vitro and in vivo","volume":"609","author":"Konishi","year":"1993","journal-title":"Brain Res"},{"key":"10.1016\/j.ijrobp.2008.06.1923_bib17","doi-asserted-by":"crossref","first-page":"9733","DOI":"10.1523\/JNEUROSCI.21-24-09733.2001","article-title":"Erythropoietin regulates the in vitro and in vivo production of neuronal progenitors by mammalian forebrain neural stem cells","volume":"21","author":"Shingo","year":"2001","journal-title":"J Neurosci"},{"key":"10.1016\/j.ijrobp.2008.06.1923_bib18","doi-asserted-by":"crossref","first-page":"4044","DOI":"10.1073\/pnas.051606598","article-title":"Erythropoietin prevents neuronal apoptosis after cerebral ischemia and metabolic stress","volume":"98","author":"Siren","year":"2001","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.ijrobp.2008.06.1923_bib19","doi-asserted-by":"crossref","first-page":"74","DOI":"10.2119\/2006-00042.Erbayraktar","article-title":"Carbamylated erythropoietin reduces radiosurgically-induced brain injury","volume":"12","author":"Erbayraktar","year":"2006","journal-title":"Mol Med"},{"key":"10.1016\/j.ijrobp.2008.06.1923_bib20","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1016\/j.ejca.2006.09.028","article-title":"Cisplatin-induced peripheral neuropathy: Neuroprotection by erythropoietin without affecting tumour growth","volume":"43","author":"Bianchi","year":"2007","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.ijrobp.2008.06.1923_bib21","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1016\/j.ijrobp.2003.12.022","article-title":"Erythropoietin-induced reduction of hypoxia before and during fractionated irradiation contributes to improvement of radioresponse in human glioma xenografts","volume":"59","author":"Pinel","year":"2004","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2008.06.1923_bib22","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1007\/s004320000215","article-title":"Recombinant human erythropoietin increases the radiosensitivity of xenografted human tumours in anaemic nude mice","volume":"127","author":"Stuben","year":"2001","journal-title":"J Cancer Res Clin Oncol"},{"key":"10.1016\/j.ijrobp.2008.06.1923_bib23","doi-asserted-by":"crossref","first-page":"1789","DOI":"10.1016\/S0002-9440(10)64314-3","article-title":"Hypoxia-inducible erythropoietin signaling in squamous dysplasia and squamous cell carcinoma of the uterine cervix and its potential role in cervical carcinogenesis and tumor progression","volume":"162","author":"Acs","year":"2003","journal-title":"Am J Pathol"},{"key":"10.1016\/j.ijrobp.2008.06.1923_bib24","doi-asserted-by":"crossref","first-page":"1525","DOI":"10.1158\/1535-7163.1525.3.12","article-title":"Erythropoietin induces cancer cell resistance to ionizing radiation and to cisplatin","volume":"3","author":"Belenkov","year":"2004","journal-title":"Mol Cancer Ther"},{"key":"10.1016\/j.ijrobp.2008.06.1923_bib25","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1016\/S0002-9440(10)62303-6","article-title":"Functional erythropoietin autocrine loop in melanoma","volume":"166","author":"Kumar","year":"2005","journal-title":"Am J Pathol"},{"key":"10.1016\/j.ijrobp.2008.06.1923_bib26","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1038\/sj.onc.1207294","article-title":"Effect of haemopoietic growth factors on cancer cell lines and their role in chemosensitivity","volume":"23","author":"Liu","year":"2004","journal-title":"Oncogene"},{"key":"10.1016\/j.ijrobp.2008.06.1923_bib27","doi-asserted-by":"crossref","first-page":"338","DOI":"10.3171\/jns.2007.106.2.338","article-title":"Survival and invasiveness of astrocytomas promoted by erythropoietin","volume":"106","author":"Mohyeldin","year":"2007","journal-title":"J Neurosurg"},{"key":"10.1016\/j.ijrobp.2008.06.1923_bib28","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1016\/j.ejca.2006.10.012","article-title":"Preclinical studies of erythropoietin receptor expression in tumour cells: Impact on clinical use of erythropoietic proteins to correct cancer-related anaemia","volume":"43","author":"Osterborg","year":"2007","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.ijrobp.2008.06.1923_bib29","first-page":"1193","article-title":"Glioblastoma multiforme cells: Expression of erythropoietin receptor and response to erythropoietin","volume":"31","author":"Yin","year":"2007","journal-title":"Int J Oncol"},{"key":"10.1016\/j.ijrobp.2008.06.1923_bib30","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1159\/000097464","article-title":"Recombinant human erythropoietin is associated with increased overall survival in patients with multiple myeloma","volume":"117","author":"Baz","year":"2007","journal-title":"Acta Haematol"},{"key":"10.1016\/j.ijrobp.2008.06.1923_bib31","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1016\/S0360-3016(01)01488-2","article-title":"Impact of hemoglobin level and use of recombinant erythropoietin on efficacy of preoperative chemoradiation therapy for squamous cell carcinoma of the oral cavity and oropharynx","volume":"50","author":"Glaser","year":"2001","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2008.06.1923_bib32","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.1016\/S0140-6736(03)14567-9","article-title":"Erythropoietin to treat head and neck cancer patients with anaemia undergoing radiotherapy: Randomised, double-blind, placebo-controlled trial","volume":"362","author":"Henke","year":"2003","journal-title":"Lancet"},{"key":"10.1016\/j.ijrobp.2008.06.1923_bib33","doi-asserted-by":"crossref","first-page":"5960","DOI":"10.1200\/JCO.2005.06.150","article-title":"Maintaining normal hemoglobin levels with epoetin alfa in mainly nonanemic patients with metastatic breast cancer receiving first-line chemotherapy: a survival study","volume":"23","author":"Leyland-Jones","year":"2005","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ijrobp.2008.06.1923_bib34","first-page":"213","article-title":"Comparative assessment of the functional p53 status in glioma cells","volume":"25","author":"Kim","year":"2005","journal-title":"Anticancer Res"},{"key":"10.1016\/j.ijrobp.2008.06.1923_bib35","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1016\/S0736-5748(99)00047-7","article-title":"Dissecting glioma invasion: Interrelation of adhesion, migration and intercellular contacts determine the invasive phenotype","volume":"17","author":"Kaczarek","year":"1999","journal-title":"Int J Dev Neurosci"},{"key":"10.1016\/j.ijrobp.2008.06.1923_bib36","doi-asserted-by":"crossref","first-page":"3639","DOI":"10.1088\/0031-9155\/51\/15\/003","article-title":"A preliminary investigation of cell growth after irradiation using a modulated x-ray intensity pattern","volume":"51","author":"Bromley","year":"2006","journal-title":"Phys Med Biol"},{"key":"10.1016\/j.ijrobp.2008.06.1923_bib37","first-page":"3897","article-title":"Determinants of human astrocytoma migration","volume":"54","author":"Giese","year":"1994","journal-title":"Cancer Res"},{"key":"10.1016\/j.ijrobp.2008.06.1923_bib38","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1016\/S0024-3205(04)00285-1","article-title":"Changes in G1-phase populations in human glioblastoma and neuroblastoma cell lines influence p66\/Be neutron-induced micronucleus yield","volume":"75","author":"Akudugu","year":"2004","journal-title":"Life Sci"},{"key":"10.1016\/j.ijrobp.2008.06.1923_bib39","doi-asserted-by":"crossref","first-page":"4934","DOI":"10.1158\/1078-0432.CCR-04-2270","article-title":"Inhibition of glioblastoma angiogenesis and invasion by combined treatments directed against vascular endothelial growth factor receptor-2, epidermal growth factor receptor, and vascular endothelial-cadherin","volume":"11","author":"Lamszus","year":"2005","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.ijrobp.2008.06.1923_bib40","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1215\/15228517-2006-034","article-title":"Imaging of brain and brain tumor specimens by time-resolved multiphoton excitation microscopy ex vivo","volume":"9","author":"Kantelhardt","year":"2007","journal-title":"Neuro Oncol"},{"key":"10.1016\/j.ijrobp.2008.06.1923_bib41","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.ejphar.2004.10.035","article-title":"Passage of erythropoietic agents across the blood-brain barrier: A comparison of human and murine erythropoietin and the analog darbepoetin alfa","volume":"505","author":"Banks","year":"2004","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.ijrobp.2008.06.1923_bib42","first-page":"6962","article-title":"Prognostic value of epidermal growth factor receptor in patients with glioblastoma multiforme","volume":"63","author":"Shinojima","year":"2003","journal-title":"Cancer Res"},{"key":"10.1016\/j.ijrobp.2008.06.1923_bib43","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s00066-008-1745-2","article-title":"Recombinant human erythropoietin alpha improves the efficacy of radiotherapy of a human tumor xenograft, affecting tumor cells and microvessels","volume":"184","author":"L\u00f6vey","year":"2008","journal-title":"Strahlenther Onkol"},{"key":"10.1016\/j.ijrobp.2008.06.1923_bib44","doi-asserted-by":"crossref","first-page":"1096","DOI":"10.1002\/cncr.22879","article-title":"Expression of erythropoietin and its receptor in neuroblastomas","volume":"110","author":"Sartelet","year":"2007","journal-title":"Cancer"},{"key":"10.1016\/j.ijrobp.2008.06.1923_bib45","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1111\/j.1365-2990.2006.00820.x","article-title":"De novo erythropoietin receptor (EPO-R) expression in human neoplastic glial cells decreases with grade of malignancy but is favourably associated with patient survival","volume":"33","author":"Mittelbronn","year":"2007","journal-title":"Neuropathol Appl Neurobiol"}],"container-title":["International Journal of Radiation Oncology*Biology*Physics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S036030160802960X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S036030160802960X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,5,20]],"date-time":"2023-05-20T04:52:49Z","timestamp":1684558369000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S036030160802960X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,11]]},"references-count":45,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2008,11]]}},"alternative-id":["S036030160802960X"],"URL":"https:\/\/doi.org\/10.1016\/j.ijrobp.2008.06.1923","relation":{},"ISSN":["0360-3016"],"issn-type":[{"value":"0360-3016","type":"print"}],"subject":[],"published":{"date-parts":[[2008,11]]}}}